Dopamine Receptor d1 Antikörper (AA 338-446)
Kurzübersicht für Dopamine Receptor d1 Antikörper (AA 338-446) (ABIN7149466)
Target
Alle Dopamine Receptor d1 (DRD1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 338-446
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human D(1A) dopamine receptor protein (338-446AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Andere Bezeichnung
- DRD1
-
Hintergrund
-
Background: Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.
Aliases: D(1A) dopamine receptor antibody, D1A dopamine receptor antibody, DADR antibody, Dopamine D1 receptor antibody, dopamine receptor D1 antibody, DR D1 antibody, DR D1A antibody, DRD 1 antibody, DRD 1A antibody, DRD1 antibody, DRD1_HUMAN antibody, DRD1A antibody
-
UniProt
- P21728
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Target
-